Parkinson’s disease is characterized by motor symptoms such as tremors, stiffness, and bradykinesia (slowed movement). Medical cannabis, particularly strains high in CBD and low in THC, may help reduce these motor symptoms. CBD has been suggested to have anti-dyskinetic effects, potentially improving movement and reducing muscle stiffness.
Parkinson’s disease can cause pain, including muscle and joint pain, as well as dystonia (sustained muscle contractions). Medical cannabis, especially strains high in CBD, has shown potential in relieving pain and reducing muscle spasms, potentially improving overall comfort.
Parkinson’s disease is not only characterized by motor symptoms but also by various non-motor symptoms such as sleep disturbances, anxiety, depression, and cognitive impairment. Medical cannabis, particularly strains high in CBD, may help manage these non-motor symptoms. CBD has been studied for its potential anxiolytic and antidepressant properties and may have a positive impact on sleep quality and cognitive function.
Levodopa, the primary medication used to manage Parkinson’s disease, can lead to levodopa-induced dyskinesia (involuntary and abnormal movements). Some studies suggest that medical cannabis, specifically strains containing THC, may help reduce levodopa-induced dyskinesia in some individuals.
Some research suggests that cannabinoids found in medical cannabis, such as CBD, may have neuroprotective properties. They may help protect brain cells from damage and reduce inflammation, which could potentially slow down the progression of Parkinson’s disease. However, further studies are needed to fully understand the extent and mechanisms of these neuroprotective effects.
We’re sorry, but you must be at least 18 years old to access the content and products on Botanical Sciences. It’s important to us to adhere to legal guidelines for the sale and promotion of cannabis-based products.